Last $0.0020 USD
Change Today 0.00 / 0.00%
Volume 0.0
AMARQ On Other Exchanges
As of 8:10 PM 07/9/14 All times are local (Market data is delayed by at least 15 minutes).

amarillo biosciences inc (AMARQ) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/10/14 - $0.06
52 Week Low
11/5/13 - $0.0005
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

amarillo biosciences inc (AMARQ) Related Businessweek News

No Related Businessweek News Found

amarillo biosciences inc (AMARQ) Details

Amarillo Biosciences, Inc. engages in the development of biologics for the treatment of human and animal diseases. It owns or licenses five issued patents related to the low-dose oral delivery of interferon; and owns one issued patent on its dietary supplement, Maxisal. The company’s principal product includes human interferon alpha, which is in the Phase II clinical trial for the treatment of influenza and hepatitis C. Amarillo Biosciences, Inc. was founded in 1984 and is based in Amarillo, Texas. On October 31, 2013, Amarillo Biosciences Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the Northern District of Texas.

3 Employees
Last Reported Date: 04/15/14
Founded in 1984

amarillo biosciences inc (AMARQ) Top Compensated Officers

Chairman, Chief Executive Officer, Member of ...
Total Annual Compensation: $38.8K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $40.8K
Compensation as of Fiscal Year 2013.

amarillo biosciences inc (AMARQ) Key Developments

Amarillo Biosciences Inc. announced delayed annual 10-K filing

On 03/28/2014, Amarillo Biosciences Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC.

Amarillo Biosciences Inc. will Change its Ticker to AMAR.Q from AMAR

Effective November 04, 2013, Amarillo Biosciences Inc. will change its Pink Sheets LLC stock ticker symbol to AMAR.Q from AMAR.

Amarillo Biosciences Inc. Announces Resignation of Martin J. Cummins as Vice President of Clinical and Regulatory Affairs

Martin J. Cummins resigned as Vice President of Clinical and Regulatory Affairs from Amarillo Biosciences Inc., effective August 31, 2013.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMARQ:US $0.00 USD 0.00

AMARQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for AMARQ.
View Industry Companies

Industry Analysis


Industry Average

Valuation AMARQ Industry Range
No financial data is available for AMARQ.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMARILLO BIOSCIENCES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at